FY25 Vaccines for Children

Closed Solicitation Posted

Solicitation number
75D30125R00065
Agency
CDC Office of Acquisition Services Centers for Disease Control and Prevention, Department of Health and Human Services
Responses due
Set-aside
No set-aside

Opportunity facts

NAICS code
325412 Pharmaceutical Preparation Manufacturing
PSC
6505 Drugs And Biologicals
Place of performance
Atlanta, Georgia 30341, United States
Points of contact

Notice details come from SAM.gov. Updated .

About this opportunity

The Centers for Disease Control and Prevention (CDC) is seeking to award contracts to manufacturers of pediatric vaccines for the Vaccines for Children (VFC) program through an Indefinite Delivery/Indefinite Quantity (IDIQ) solicitation. The procurement aims to purchase standard commercial pediatric vaccines to support immunization efforts for eligible children, including those who are Medicaid-eligible, uninsured, American Indian/Alaska Native, or have insurance that does not cover vaccines. Offerors must be vaccine manufacturers as defined under 42 U.S.C. 1396s, with FDA licensing and the ability to provide vaccines with a minimum 12-month shelf life. The solicitation will evaluate proposals based on technical capability, pricing, and past performance, with key deadlines including January 23, 2025, for questions and January 30, 2025, at 1:00 PM EST for proposal submissions. Contractors must provide electronic data interchange capabilities and be able to interface with CDC's Vaccine Tracking System (VTrckS).

The solicitation is unrestricted, with no specific small business set-aside, though the CDC has small business participation goals for 2025. Delivery of vaccines will be required within 15 working days to CDC distribution centers located in Olive Branch, MS, Aurora, CO, and Clermont, KY. The contract period will span 12 months from the date of award, specifically from April 1, 2025, through March 31, 2026. While specific award values are not explicitly stated, the vaccine order limitation chart indicates potential maximum order quantities ranging from 100 doses to 13 million doses for different vaccine types. Contractors will be required to include Federal Excise Tax in their pricing, with rates varying from $0.75 to $4.50 per dose depending on the vaccine type. The place of performance is primarily centered in Chamblee, GA 30341, with distribution occurring through multiple CDC distribution centers.

Notice text

The Centers for Disease Control and Prevention (CDC) awards contracts to the manufacturers of pediatric vaccines for the purchase of standard commercial pediatric vaccines.  Vaccines are one of the most cost-effective ways to prevent disease and reduce healthcare costs. The Vaccine for Children (VFC) program, established pursuant to Section 13631 of the Omnibus Budget Reconciliation Act of 1993 (OBRA ’93), guarantees federal support for the purchase and supply of sufficient quantities of vaccine to the States to cover a defined group of children.  The program helps assure the implementation of effective immunization practices and proper use of vaccines to achieve higher immunization coverage.  Children (18 years-of-age or younger) who qualify for immunization through the VFC purchase program include those who are (1) Medicaid-eligible, (2) without health insurance, (3) American Indian/Alaska native (as defined in Subsection (h)(3) of the OBRA ’93), or (4) children with health insurance, which does not cover the cost of vaccines, if they receive their immunizations at a Federally-qualified health center or rural health clinic (as defined by the Social Security Act).  Health care providers who agree to certain requirements are eligible through the States to receive free vaccine through this VFC purchase program.  The establishment of these contracts provides an opportunity to utilize VFC funds and Section 317 vaccine purchase funds to obtain vaccines at prices below those available in the commercial marketplace.  In addition, awardees may opt to purchase additional quantities of vaccine under any resulting contract to provide immunizations for children who are not federally vaccine-eligible children using state and local funds. Offerors for this requirement must be manufacturers of pediatric vaccines in accordance with 42

U.S.C. § 1396s. The term "manufacturer" means any corporation, organization, or institution, whether public or private (including Federal, State, and local departments, agencies, and instrumentalities), which manufactures, imports, processes, or distributes under its label any pediatric vaccine. The term "manufacture" means to manufacture, import, process, or distribute a vaccine.

Attachments

Files attached to this notice, newest first
File Type Posted
A19 Solicitation - 75D30125R00065.pdf PDF
A19 Solicitation - 75D30125R00065.pdf PDF
A19 Solicitation - 75D30125R00065.pdf PDF
A19 Vaccine Order Limitation Chart.docx DOCX document
A19 Authorized Distributor of Record (ADR) Agreement.docx DOCX document

On GovTribe

Work this opportunity on GovTribe

  • Track it in your pipeline
  • Find teaming partners
  • Similar opportunities
  • Ask GovTribe AI about this opportunity